首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Lancet diabetes & endocrinology

缩写:

ISSN:2213-8587

e-ISSN:2213-8595

IF/分区:41.8/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2800
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ildiko Lingvay,Sara J Bergenheim,John B Buse et al. Ildiko Lingvay et al.
Background: Semaglutide 2·4 mg is approved for weight management in adults with obesity or overweight in the presence of at least one obesity-related complication; however, many people with obesity and type 2 diabetes do...
Sean Wharton,Paula Freitas,Jøran Hjelmesæth et al. Sean Wharton et al.
Background: Once-weekly subcutaneous semaglutide 2·4 mg is approved for weight management in people with obesity and related complications; however, some individuals do not reach their therapeutic goals with this dose. W...
Kiran Jobanputra,Sigiriya Aebischer Perone,Éimhín Ansbro et al. Kiran Jobanputra et al.
People with non-communicable diseases (NCDs) are particularly vulnerable to health service disruptions resulting from conflicts, natural disasters, and major disease outbreaks. The 2018 Political Declaration of the 3rd UN High-Level Meeting...
Lauryn K Stafford,Anna Gage,Yvonne Yiru Xu et al. Lauryn K Stafford et al.
Background: Diabetes is a serious global health challenge, with a rising prevalence and substantial effect on disability and mortality worldwide. Despite medical advancements, gaps in the cascade of diabetes care-comprisi...